Ms. Imola Mihalecz is leading a research project on chronic pain in Parkinson’s disease, an often overlooked but significant symptom. By analyzing pain perception in PD patients, Mihalecz hopes to improve pain management and develop tailored treatment strategies.
In the Summer edition of Viewpoints, Dr. Jonathan Squires joins us to discuss the brain health benefits of improvisation for people with Parkinson's disease (PD), including improved communication and theability to handle unpredictable situations better. In addition,...
We are excited to announce a new drop-in service at the Kelowna Movement Disorder Clinic, offering timely advice and expert direction for Parkinson's resources. The team of Social Workers, Speech-Language Pathologists, and Physical Therapists is available to support...
Identical twin brothers Jim and Pat Smerdon enjoyed a childhood rich with shared adventure, discovery, and the types of playful jokes one can only get away with as a twin. “We were known to have switched classes in school to play tricks on unsuspecting teachers,” Pat...
Until a few years ago, Catherine Pezarro was a career person with a highly active lifestyle. She enjoyed a variety of activities, from regular running, skiing, and yoga sessions, to trying sports like tennis and figure skating. Summer days were spent cycling and...
Researchers at the University of British Columbia are developing a wearable device to help Parkinson’s disease patients manage their L-dopa medication more effectively. The study, led by Dr. Martin McKeown, uses the Empatica EmbracePlus wristband, which tracks physiological data such as heart rate and skin temperature, to predict when a patient’s medication is wearing off. This personalized approach aims to alert patients to take their next dose before symptoms appear, improving medication timing and overall quality of life.
Parkinson Society British Columbia (PSBC) is pleased to announce the appointment of Dr. Joanne Baker (PhD) as the new Chief Executive Officer (CEO),
In response to the discontinuation of Movapo, an essential medication for managing hypomobility in advanced Parkinson’s disease, Canadians now have access to an alternative treatment option. APO-go® PEN, containing the ingredient apomorphine hydrochloride, has been...
In the Spring edition of Viewpoints, British Columbia's newly-appointed Deep Brain Stimulation neurosurgeon, Dr. Stefan Lang, discusses this lifechanging treatment for people with Parkinson's disease (PD).Additionally, April is Parkinson's Awareness Month. This is an...
